Purchase Order 75N95023P00383
Award Date 6/21/23
Potential Completion Date 6/19/24
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...
- This is a $15,650.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Novandi Chemistry AB, a for-profit manufacturer of goods. The contract is for the supply of tritiated cocaine to support binding experiments investigating how novel receptors interact with drugs in vivo. Novandi Chemistry AB is a vendor that specializes in providing radioactive materials and custom synthesis services for drug...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $12,087 purchase order to Med Associates, Inc., doing business as Med Associates, for unspecified services or products. The contract has a one-year period of performance beginning July 7, 2023 through July 6, 2024 and utilizes a firm fixed price contracting structure. Place of performance will be Med Associates' Baltimore, Maryland location. No additional details were...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $11,685 purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. The firm fixed price contract is to provide research and development systems in support of NIH/NIDA programs addressing substance abuse and addiction. Performance will take place in Minneapolis over a two week period concluding on August 1, 2023. No subcontractors or set aside designations were...
- <p>The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a Firm Fixed Price purchase order contract to Trevena, Inc. for $156,410.00. The contract was not set aside for a specific business type. The work will be performed in Chesterbrook, Pennsylvania and is scheduled for completion by August 31, 2019. This contract award is associated with the broader NIH research program focused on drug abuse and addiction.</p>
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Novandi Chemistry AB, a manufacturer of goods. The $10,400.00 contract is for the delivery of radioactive materials, including tritium, carbon 14, and stable labeling chemistry services, to support research related to drugs of abuse. Novandi Chemistry AB has previously provided similar specialty chemicals to other NIH...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,825 purchase order to Sigma-Aldrich, Inc. for contract 1107546 under contract number 23-005532. Performance will take place in Baltimore, Maryland over the course of one year beginning in September 2023. The firm fixed price contract is for the procurement of products or services to support NIH/NIDA research efforts, though details of the work were not provided....
- The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $83,854 delivery order contract to Neta Scientific Inc. under the company's Multiple Award Schedule contract vehicle. Neta Scientific, a division of Neta Scientific Inc., will provide unspecified products or services to the National Institute on Drug Abuse in Rockville, Maryland under the one-year firm fixed price contract running from August 2023 through August 2024. No...
- This is a $49,998.42 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to Bar-Haim Yair, a non-profit organization located in Rockville, Maryland. The contract has an ultimate completion date of June 4, 2025 and was awarded on July 3, 2023. The contract does not have a set-aside designation. Based on the agency, this contract is likely related to the National Institute on Drug Abuse's research and programmatic initiatives focused...
- The National Institute on Drug Abuse awarded a $789,585 cost-plus-fixed-fee delivery order contract to The Emmes Company LLC under its Data, Statistics, and Clinical Trial Support Center indefinite delivery/indefinite quantity contract vehicle. The delivery order is to conduct an ancillary study of the adoption and sustainability of buprenorphine initiated through emergency departments, supporting NIDA's mission to advance science on the causes and consequences of drug use and addiction....
The National Institutes of Health's National Institute on Drug Abuse awarded a $14,900 firm fixed price purchase order to Novandi Chemistry AB of Baltimore, Maryland. The contract calls for the delivery of tritiated heroin to support binding experiments investigating how heroin and its metabolites bind in vivo. As the lead federal agency supporting scientific research on drug abuse and addiction, the National Institute on Drug Abuse uses contracts such as this to further its mission of advancing science on the health risks and consequences of drug use and apply those findings to improve prevention and treatment. No set aside designation or subcontractors were indicated for this contract.
Generated 12/18/23, 6:37 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 6/21/23 |